OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early Identification, Accurate Diagnosis, and Treatment of Silicosis
Tian Li, Xinyu Yang, Hong Xu, et al.
Canadian Respiratory Journal (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease
Claudia Mariana Handra, Irina Luciana Gurzu, Marinela Chirilă, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 5, pp. 96-96
Open Access | Times Cited: 27

The role of inflammation in silicosis
Tong‐Tong Liu, Hai-Fei Sun, Yanxing Han, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 15

Switchable and Tunable Radiative Cooling: Mechanisms, Applications, and Perspectives
Xuzhe Zhao, Jiachen Li, Kaichen Dong, et al.
ACS Nano (2024) Vol. 18, Iss. 28, pp. 18118-18128
Closed Access | Times Cited: 13

Macrophage-derived exosomal HMGB3 regulates silica-induced pulmonary inflammation by promoting M1 macrophage polarization and recruitment
Xiaofeng Qin, Zhiyuan Niu, Hui Chen, et al.
Particle and Fibre Toxicology (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 8

Potential Health Impacts, Treatments, and Countermeasures of Martian Dust on Future Human Space Exploration
Justin Wang, Jeremy J Rosenbaum, A.N. Prasad, et al.
GeoHealth (2025) Vol. 9, Iss. 2
Open Access | Times Cited: 1

Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases
Daniela Mokrá, Juraj Mokrý, Romana Barošová, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1713-1713
Open Access | Times Cited: 22

From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis
Rou Li, Huimin Kang, Shi Chen
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8333-8333
Open Access | Times Cited: 16

Quercetin Alleviates Pulmonary Fibrosis in Silicotic Mice by Inhibiting Macrophage Transition and TGF-β-Smad2/3 Pathway
Fei Geng, Lan Zhao, Yuhao Cai, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3087-3101
Open Access | Times Cited: 13

Association between silicosis and autoimmune disease
Elizabeth Fireman, Einat Fireman Klein
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 2, pp. 45-50
Open Access | Times Cited: 5

Nebulized inhalation of LPAE-HDAC10 inhibits acetylation-mediated ROS/NF-κB pathway for silicosis treatment
Yunze Tian, Hongyang Shi, Danjie Zhang, et al.
Journal of Controlled Release (2023) Vol. 364, pp. 618-631
Open Access | Times Cited: 11

Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway
Cunxiang Bo, Fang Liu, Zewen Zhang, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4



International Journal of Pharmaceutical Sciences and Research (2025) Vol. 16, Iss. 1
Open Access

Erasmus Syndrome, An Autoimmunity Paradox: A Case Report and Literature Review
Alejandro Arango, Simon Villa-Pérez, Jhon Edwar García-Rueda, et al.
Cureus (2025)
Open Access

Fermented Cordyceps Powder Alleviates Silica-induced Inflammation and Fibrosis by Inhibiting M1 Macrophage Polarization via the HMGB1-TLR4-NF-κB Pathway
Shuangshuang Pu, Xiangjing Meng, Yushan Shi, et al.
Journal of Ethnopharmacology (2025), pp. 119631-119631
Closed Access

Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis
Xiaolong Cai, Ying Bai, Chao Liang, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114458-114458
Closed Access

Ingenol ameliorates silicosis via targeting the PTGS2/PI3K/AKT signaling axis: Implications for therapeutic intervention
Yifan Jing, Ying Bai, Chao Liang, et al.
Cellular Signalling (2025), pp. 111780-111780
Closed Access

Forty-five-year-old man with small nodular and ground-glass opacities on CT
Jiping Liao, Xiaoquan Chen, Guo Yu Qiu, et al.
Thorax (2025), pp. thorax-222806
Closed Access

Tuberculosis and Silicosis: an insightful perspective
S Pandit, Sudatta Chandan, Braja Sundar Barik, et al.
Egyptian Journal of Chest Diseases and Tuberculosis (2025) Vol. 74, Iss. 2, pp. 134-146
Open Access

Exercise training inhibits macrophage-derived IL-17A-CXCL5-CXCR2 inflammatory axis to attenuate pulmonary fibrosis in mice exposed to silica
Fuyu Jin, Yaqian Li, Xuemin Gao, et al.
The Science of The Total Environment (2023) Vol. 902, pp. 166443-166443
Closed Access | Times Cited: 10

Celastrol as a candidate drug for silicosis: From bioinformatics and network pharmacology to experimental validation
Chao Liang, Ying Bai, Rui Miao, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111068-111068
Closed Access | Times Cited: 9

Paeoniflorin mitigates MMP-12 inflammation in silicosis via Yang-Yin-Qing-Fei Decoction in murine models
Tian Li, Na Mao, Zihao Xie, et al.
Phytomedicine (2024) Vol. 129, pp. 155616-155616
Closed Access | Times Cited: 3

Bicyclol attenuates pulmonary fibrosis with silicosis via both canonical and non-canonical TGF-β1 signaling pathways
Tong-Tong Liu, Hai-Fei Sun, Ming-Ze Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top